Ukr.Biochem.J. 2017; Volume 89, Issue 2, Mar-Apr, pp. 106-115


Complexes of palladium(II) with 1-phenyl-1-hydroxymethylene bisphosphoniс acid and their antitumor activity

O. M. Kozachkova1, N. V. Tsaryk1, V. V. Trachevskyi2,
A. B. Rozhenko3, Yu. H. Shermolovich3, O. I. Guzyr3,
N. I. Sharykina4, V. F. Chekhun5, V. I. Pekhnyo1

1Vernadsky Institute of General and Inorganic Chemistry,
National Academy of Sciences of Ukraine, Kyiv;
2Technical Centre of National Academy of Sciences of Ukraine, Kyiv;
3Institute of Organic Chemistry, National Academy of Sciences of Ukraine, Kyiv;
4SI “Institute of Pharmacology and Toxicology, National Academy
of Medical Sciences of Ukraine”, Kyiv;
5Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences of Ukraine, Kyiv;

Complex formation of K2[PdCl4] with 1-phenyl-1-hydroxymethylene bisphosphonic acid (PhHMBP, H4L) has been studied by pH potentiometry, electron and NMR spectroscopy. It was found that in aqueous solution with physiological concentration of chlorine anions (0.15 mol/l KCl), anionic complexes of the equimolar compositions [PdHLCl2]3- (lgβ = 24.51 (0.3)) and [PdLCl2]4- (lgβ = 20.74 (0.02)) are formed. In the first coordination sphere palladium was surrounded by two oxygen atoms of two phosphonic groups of the bidentately coordinated ligand with closure of six-membered [O, O] ring, and two chlorine anions. The formation of palladium(II) equimolar complexes with PhHMBP and bidentate coordination of the ligand to the central metal cation was confirmed by 31P NMR spectroscopy. Cytotoxic activity (IC50 based on metal content) of the synthesized Pd(II) complexes with PhHMBP against human MG-63 osteosarcoma and MCF-7 mammary tumor cells was compared with cisplatin on in vitro models. It was established that cytotoxic activity of the Pd complexes was lower than that of cisplatin. The acute toxicity (LD50 based on metal content) of solutions of Pd(II) complexes with PhHMBP was found to be lower compared to cisplatin. It was shown that the use of solutions of palladium(II) complexes with PhHMBP inhibited tumor growth in mice with sarcoma 180.

Keywords: , , ,


  1. Abu-Surrah AS, Kettunen M. Platinum group antitumor chemistry: design and development of new anticancer drugs complementary to cisplatin. Curr Med Chem. 2006;13(11):1337-57. Review. PubMed, CrossRef
  2. Kapdi AR, Fairlamb IJ. Anti-cancer palladium complexes: a focus on PdX2L2, palladacycles and related complexes. Chem Soc Rev. 2014 Jul 7;43(13):4751-77. Review. PubMed, CrossRef
  3. Sharma NK, Ameta RK, Singh M. Biological Impact of Pd (II) Complexes: Synthesis, Spectral Characterization, In Vitro Anticancer, CT-DNA Binding, and Antioxidant Activities. Int J Med Chem. 2016;2016:9245619.  PubMed, PubMedCentral, CrossRef
  4. Keswani T, Chowdhury S, Mukherjee S, Bhattacharyya A. Palladium(II) complex induces apoptosis through ROS-mediated mitochondrial pathway in human lung adenocarcinoma cell line (A549). Curr Sci. 2014;107(10):1711-1719.
  5. Abu-Surrah AS, Al-Sa’doni HH, Abdalla MY. Palladium-based chemotherapeutic agents: Routes toward complexes with good antitumor activity. Cancer Therapy. 2008;6:1-10.
  6. Zhang S, Gangal G, Uludağ H. ‘Magic bullets’ for bone diseases: progress in rational design of bone-seeking medicinal agents. Chem Soc Rev. 2007 Mar;36(3):507-31. Review. PubMed, CrossRef
  7. Zolotukhina MM, Krutikov VI, Lavrent’ev AN. Derivatives of diphosphonic acids: synthesis and biological activity. Russ Chem Rev.1993;62(7):647–659. CrossRef
  8. Margiotta N, Ostuni R, Teoli D, Morpurgo M, Realdon N, Palazzo B, Natile G. Bisphosphonate complexation and calcium doping in silica xerogels as a combined strategy for local and controlled release of active platinum antitumor compounds. Dalton Trans. 2007 Aug 7;(29):3131-9. PubMed, CrossRef
  9. Puthraya KH, Srivastava TS, Amonkar AJ, Adwankar MK, Chitnis MP. Some mixed-ligand palladium(II) complexes of 2,2′-bipyridine and amino acids as potential anticancer agents. J Inorg Biochem. 1985 Nov;25(3):207-15. PubMed, CrossRef
  10. Lecouvey M, Mallard I, Bailly T, Burgada R, Leroux Y. A mild and efficient one-pot synthesis of 1-hydroxymethylene-1, 1-bisphosphonic acids. Preparation of new tripod ligands. Tetrahedron Lett. 2001;42(48):8475-8478. CrossRef
  11. Chernyaev I. Synthesis of Complex Compounds of Platinum Group Metals. Moscow: Nauka, 1964. 266р. (In Russian).
  12. Ginzburg I, Ezerskaya NA, Prokof’eva IV, Fedorenko NV, Shlenskaya VI, Relskii NK. Analytical Chemistry of Platinum Metals. Moscow: Nauka, 1972. 613 р. (In Russian).
  13. Zekany L, Nagypal I. Computational methods for the determination of formation constants. New York: Plenum Press, 1985;291-353 p.
  14. Elding LI.Palladium(II) halide complexes. I. Stabilities and spectra of palladium(II) chloro and bromo aqua complexes. Inorg Chim Acta. 1972;6:647-651.  CrossRef
  15. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983 Dec 16;65(1-2):55-63. PubMed, CrossRef
  16. Prozorovsky VB. Tabular Express Method of determining the average effective measures of influence on biological objects. Toxicological Review. 1998;1:28-32. (In Russian).
  17. Stephanov OV. Pre-clinical study of medicine. Kyiv: Avicenna, 2001. 528p. (In Ukrainian).
  18. Gumienna-Kontecka E, Silvagni R, Lipinski R, Lecouvey M, Marincola FC, Crisponi G, Nurchi VM, Leroux Y, Kozlowski H. Bisphosphonate chelating agents: complexation of Fe(III) and Al(III) by 1-phenyl-1-hydroxymethylene bisphosphonate and its analogues. Inorg Chim Acta. 2002;339:111-118.  CrossRef
  19. Kozachkova AN, Tsaryk NV, Kostromina NA, Pekhnyo VI. Cis-diaminodichloropalladium(II) and hydroethylenediphosphonic acid interaction. Ukr Khim Zhurn. 2007;73(3):15-19. (In Ukrainian).
  20. Kozachkova AN, Dudko AV, Tsaryk NV, Trachevskii VV, Rozhenko AB, Pekhnyo VI. Different Ways of Coordination for Aminoalkyldiphosphonic Acids in Palladium(II) Complexes. Rus J Coord Chem. 2011;37(12):941–948. CrossRef

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.